Arkolith/Insider Trading/SCTX/Form 4

Lucas Svetlana

Chief Business OfficerScribe Therapeutics, Inc. (SCTX) · full profile →Form 4 · filed Jul 28, 2026
Net Buying
Open-Market Buys
$45K
Open-Market Sells
$0
Net Open-Market Flow
$45K
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 23, 2026Buy(P)3K$15.00$45K3K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 23, 2026Grant(A)109K—$0109K
Jul 23, 2026Grant(A)109K—$0109K
Mar 13, 2026Grant(A)10K—$010K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001781292-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML